ClinicalTrials.gg
Enrolling by invitationNCT07713706Updated Nov 5, 2026

Neural Mechanisms for Stopping Ongoing Speech Production (Study 2)

An interventional study of Speech Production Tasks in Epilepsy and Speech, sponsored by University of Pittsburgh. Enrolling by invitation at 1 site in United States. Open to participants aged 8 Years to 26 Years. Per ClinicalTrials.gov, last updated 2026-11-05.

Sponsored by University of Pittsburgh · Not applicable, Interventional, and Basic science

Updated Nov 5, 2026Start date movedSponsor changedGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
12
Allocation
Not applicable
Ages
8 Years to 26 Years
Sex
All
01

Study summary

Speech and communication disorders often result in aberrant control of the timing of speech production, such as making improper stops at places where they should not be. During normal speech, the ability to stop when necessary is important for maintaining turn-taking in a smooth conversation. Existing studies have largely investigated neural circuits that support the preparation and generation of speech sounds. It is believed that activity in the prefrontal and premotor cortical areas facilitates high-level speech control and activity in the ventral part of the sensorimotor cortex controls the articulator (e.g. lip, jaw, tongue) movements. However, little is known about the neural mechanism controlling a sudden and voluntary stop of speech. Traditional view attributes this to a disengagement of motor signals while recent evidence suggested there may be an inhibitory control mechanism. This gap in knowledge limits our understanding of disorders like stuttering and aphasia, where deficits in speech timing control are among the common symptoms. The overall goal of this study is to determine how the brain controls the stopping of ongoing speech production to deepen our understanding of speech and communication in normal and impaired conditions.

Read the detailed description

Intracranial electroencephalography (iEEG) is a state-of-the-art technique with fine spatial and temporal resolutions that are well suited for studying the neural dynamics of speech. This study proposes to assess speech production in patients who are undergoing iEEG recording to carry out clinical procedures for indications related to their medical condition. The research study team will investigate neural signals correlated with speech stopping using speech production and stopping tasks with visual cues. The research study team will compare effects on neural activity within each individual subject and identify common patterns of activity across subjects. The aims of this study seek to determine the role of the premotor network for stopping during naturalistic usage. This study will provide basic knowledge for the precise control of speech stopping and the control of speech timing in general, bridging the current speech production studies to real-world communication conditions, and help inspire new theories of speech motor control.

02

Conditions studied

  • Epilepsy
  • Speech

Browse trials for

03

In context

Epilepsy

1,848 studies on the registry are indexed under Epilepsy; 422 are open to participants now.

This study's planned enrollment of 12 is below the median of 50 across 1,239 interventional studies indexed under Epilepsy.

Browse Epilepsy studies →

Lead sponsor

University of Pittsburgh is the lead sponsor of 1,419 studies on the registry; 168 are open to participants now.

Of its 9 completed or terminated interventional studies of FDA-regulated products, 4 (44%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
8 Years to 26 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Undergoing iEEG placement in regions of interest (e.g., in the frontal or temporal cortex) for clinically necessary localization of epileptic foci or language mapping
  • Fluent English speakers
  • Within the normal range for cognitive, speech-language, and hearing capacity
  • Normal or corrected-to-normal visual acuity

Exclusion criteria

Exclusion Criteria:

  • Individuals with intellectual disability
  • Lack of fluent English comprehension/production
  • Inadequate speech ability for the research tasks.
  • History of autism or ADHD
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
12 participants (estimated)

Study arms

  • Experimental
    Voice and iEEG recording during Speech Production Tasks

    Behavioral: Speech Production Tasks

Interventions

  • BehavioralSpeech Production Tasks

    View visual cues and undergo speech production.

06

What researchers measure

Primary outcomes

  1. Mean Change in Neural Activity

    Neural signal recorded at each electrode (measured in voltage) is bandpass-filtered and converted to analytic amplitude using Hilbert transform, and then Z-scored relative to the entire recording block period for that electrode. A Z-score of 0 represents the mean neural activity within the recording block period, during which the task is performed. A positive Z-score indicates higher neural activity compared to the block mean. The mean change in neural activity was calculated as the difference between the average Z-score in two time windows (\~1 second after the visual cue vs. \~1 second before), averaged across trials for each electrode and then across electrodes from all participants. Positive values of the mean change in neural activity indicate that neural activity was increased after the visual cue. Since the Z-score used here is a normalized neurophysiological measure rather than a clinical scale, there are no established thresholds or definitions of better or worse outcomes.

    Time frame: During inpatient hospitalization, up to 14 days after surgical electrode implantation

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No — IPD will not be shared due to privacy concerns associated with intracranial data.

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Start date
Sep 1, 2026→Jan 2027
Nov 5, 2026
Sponsor
Lingyun Zhao→University of Pittsburgh
Nov 5, 2026
Show all 1 update
  1. Nov 5, 2026
    Start date Sep 1, 2026→Jan 2027
    Sponsor Lingyun Zhao→University of Pittsburgh
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07713706
Responsible party
Lingyun Zhao (Assistant Professor, University of Pittsburgh) — Principal investigator
First posted
Jul 20, 2026
Start date
Jan 2027 (estimated)
Primary completion
Jul 31, 2028 (estimated)
Completion
Jul 31, 2028 (estimated)
Last update
Nov 5, 2026

Study contacts

Lingyun Zhao, PhD
principal investigator · University of Pittsburgh

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion